An efficient prodrug-based nanoscale delivery platform constructed by water soluble eight-arm-polyethylene...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Tumor drug resistance significantly limits the effectiveness of many anticancer drugs.
• Combination therapy is a strategy to combat drug resistance, but simple mixing of drugs can lead to side effects and reduced efficacy.
• Developing advanced drug delivery systems is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To create a self-assembled nanoparticle platform for co-delivering anticancer drugs.
• To enhance the efficacy of combination therapy against drug-resistant cancers.
• To evaluate the therapeutic potential of the developed nanoparticle system.

Main Methods:

• Synthesized an eight-arm-polyethylene glycol-diosgenin (8armPEG-DGN) conjugate.
• Prepared 8armPEG-DGN/HCPT nanoparticles via nanoprecipitation.
• Characterized nanoparticle size, drug loading capacity, cellular uptake, cytotoxicity, and in vivo anti-tumor effects.

Main Results:

• The 8armPEG-DGN/HCPT nanoparticles exhibited a suitable size (~107 nm) and high drug loading capacity.
• Nanoparticles significantly increased intracellular uptake in B16 cells compared to free drugs.
• The nanoparticle formulation showed lower IC50 values and superior tumor growth inhibition in vivo compared to free drugs and physical mixtures.

Conclusions:

• The 8armPEG-DGN/HCPT nanoparticle system is an effective drug delivery platform for cancer therapy.
• This system demonstrates potential for overcoming drug resistance and improving anticancer efficiency.
• Further development of this nanoparticle platform could lead to improved cancer treatment strategies.